Please assess the completion status of the following clinical trial:

Trial Title: Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features.~  1. corneal epithelial defect with stromal infiltration~ 2. reaction in anterior chamber~ 3. positive for bacteria or fungus~* The patients have to receive subconjunctival antibiotic injection twice at least.~* The patients must be informed consent.~Exclusion Criteria:~* The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs.~* The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection.~* Unable to cooperate with the treatment.~* Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- NSS/Lidocaine (Type: EXPERIMENTAL): First injection: Normal saline Second injection: 2% Lidocaine without adrenaline
- Lidocaine/NSS (Type: EXPERIMENTAL): First injection: 2% Lidocaine without adrenaline Second injection: Normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).